CombiMatrix Announces Multicycle Offering for Pre-Implantation Genetic Screening and Improved Cost Efficiencies

CombiMatrix Corporation CBMX, a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis, postnatal developmental disorders, and pre-implantation genetic screening (PGS) services, today announced that it has launched its PGS Multicycle Program. The PGS Multicycle Program provides patients the flexibility of testing eight embryos over the course of 12 months for a one-time payment. CombiMatrix is the pioneer in per-embryo pricing in conjunction with PGS testing. With the addition of a multicycle PGS option, CombiMatrix continues to offer the most flexible, cost-effective solutions for patients while increasing the upfront cash payments received for genetic testing services. "By offering the PGS Multicycle Program, we are making PGS more cost effective for physicians and their patients. We are delighted to provide an additional option to our existing flexible ‘per embryo' pricing structure, where patients pay only for those embryos being tested," said Mark McDonough, President and Chief Executive Officer of CombiMatrix. "In leveraging our commercial expertise and offering disruptive solutions such as the only nationwide PGS testing program with built-in shipping cost for transparency, we are further strengthening our position in this growing market." "Additionally, we have implemented PGS shipping process improvements, resulting in increased convenience to physicians and embryologists, as well as providing significant cost reductions. This gives us operating leverage and allows us to pass further savings onto IVF clinics and their patients," McDonough added. CombiMatrix employs innovative ways to provide unique, value-added options to its offerings, such as: No separate charge for embryo batching Pre-labeled barcode scanning for extra embryo security and tracking Biopsy services utilizing CombiMatrix embryologist and equipment (laser provided) Free access to the company's embryologist for PGS customers Easy-to-use online provider portal to view status reports "Our continued focus on our customers and their patients is evident in the high-tech, high-touch approach to our service offerings," concluded McDonough.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!